Enovis CORP PE ratio ENOV

Share price divided by earnings per share over the last twelve months, since 2014.

Today, Oct 23, 2026: n/m; losses over the last year
Last meaningful: 130×; Feb 2023
10-year median: 23.7×
10-year range: 10.7× to 152×
Peer median: 31.2×

Enovis CORP has no meaningful PE ratio today: it lost $19.26 a share over the last twelve months, and a PE needs earnings.

It was last meaningful in Feb 2023, at 130×.

On the days it had one over the last ten years, its median was 23.7×, from 10.7× in Mar 2019 to 152× in Feb 2023.

PE ratio over time

median 23.7×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2023	130×	130×	152×
2022	124×	21.0×	134×
2021	37.1×	35.6×	79.7×
2020	n/m a value too high to mean anything
2019	17.4×	10.7×	19.5×
2018	13.0×	13.0×	16.9×
2017	16.0×	14.4×	22.3×
2016	18.9×	7.1×	20.6×
2015	8.2×	7.7×	11.3×
2014	11.4×	10.3×	28.1×

Against its peers

Companies in Medical - Instruments & Supplies nearest Enovis CORP's size, closest first, today.

Company	PE ratio
ENOVEnovis CORP	n/m
BVSBioventus	19.4×
CDRECadre	37.0×
STAAStaar Surgical	323×
IRMDIradimed	47.9×
EYENational Vision	30.6×
LMATLemaitre Vascular	29.6×
INSPInspire Medical Systems	15.4×
MOVMovado	17.5×
UFPTUFP Technologies	31.9×
MDXGMimedx	97.8×
Peer median	31.2×

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Enovis CORP

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.